Alzheimer's disease (AD) and Parkinson's disease (PD) are two NDs with similar pathologies that could be treated by controlling PREP levels. The NEUROPRO project brought together eight academic institute and three small and medium-sized companies (SMEs) to provide the skills required to transform research into commercial technologies for clinical use.
Leo Tolstoy